Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

HIV Clinical Trial

Official title:

Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02468544
• Other study ID #: AAAO7902
• Status: Withdrawn
• Phase: N/A
• Start date: March 2017
• Est. completion date: April 2017

Study information

• Verified date: November 2020
• Source: Columbia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is an open-trial pilot study in which adult methadone maintenance treatment patients who are living with HIV but are not engaged in HIV primary care (i.e., missed appointments, non-adherence to medication) will be recruited to participate in a HIV primary care engagement study. The purpose of this study is to develop and test the feasibility and acceptability of a mobile phone-based health (mHealth) text messaging intervention to improve engagement in HIV primary care among substance abusing populations with HIV.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: April 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• Client of a methadone maintenance treatment program

• HIV positive (status confirmed by medical records)

• At least 18 years of age

• English speaking

• Comfortable using a mobile phone (to send and receive text messages)

• Lives in New York City

• Willingness to attend at least two design sessions

• Willingness to attend one usability testing session, and participate in a post-usability survey and exit interview.

Related Conditions & MeSH terms

• Adherence
• HIV

Intervention

Other:
• Text messaging
Text messaging mHealth intervention to improve HIV Primary Care Engagement among clients of methadone maintenance treatment programs who are living with HIV.

Locations

Country	Name	City	State
United States	Acacia Network/Promesa	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Self-efficacy to self-manage HIV infection	Changes in self-efficacy to self-manage HIV infection will be measured using the self-management scale applied to persons with HIV/AIDS.	30 days
Other	Improvements in HIV knowledge	Improvements in HIV knowledge will be measured by changes in HIV knowledge. We will use the HIV Knowledge Questionnaire (HIV-KQ-18) at baseline and at 30 days post baseline assessments to measure changes in HIV knowledge.	30 days
Primary	Acceptability of Intervention	Acceptability of the intervention will be measured using the Technology Acceptance Model (TAM) scale.	30 days
Primary	Feasibility of Intervention	Feasibility of the intervention will be assessed focusing on study implementation, including recruitment and attrition rates.	30 days
Secondary	Efficacy of the intervention	Preliminary efficacy of the intervention will be measured using the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES) and the HIV appointment adherence questionnaire.	30 days